Telomere sequence content can be used to determine ALT activity in tumours
Michael Lee, Erdahl T Teber, Oliver Holmes, Katia Nones, Ann-Marie Patch, Rebecca A Dagg, Loretta MS Lau, Joyce H Lee, Christine E Napier, Jonathan W Arthur, Sean M Grimmond, Nicholas K Hayward, Peter A Johansson, Graham J Mann, Richard A Scolyer, James S Wilmott, Roger R Reddel, John V Pearson, Nicola Waddell, Hilda A Pickett
Nucleic Acids Research | OXFORD UNIV PRESS | Published : 2018
Awarded by Cancer Council NSW
Awarded by National Health and Medical Research Council of Australia
Melanoma Institute Australia; Bioplatforms Australia; New South Wales Ministry of Health; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy; Cancer Council NSW [RG 14-16 and RG 16-09 to H.A.P.]; National Health and Medical Research Council of Australia [1051897 to H.A.P. and R.R.R.; 1093017 to G.J.M., N.K.H. and R.A.S.; fellowships to L.M.S.L., N.K.H., N.W., R.A.S. and J.S.W.]; Cancer Institute NSW [fellowships to H.A.P. and L.M.S.L.]; Kids Cancer Alliance [top-up scholarships to R.A.D. and M.L.]; Harry Banks Sutherland Rotary PhD scholarship to R.A.D.; Australia Postgraduate Award to M.L. Funding for open access charge: Children's Medical Research Institute.